adamantane has been researched along with neurotensin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 15 (62.50) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachy, A; Boigegrain, R; Gully, D; Kitabgi, P; Labbé-Jullié, C; Labeeuw, B; Le Fur, G; Maffrand, JP; Oury-Donat, F; Pecceu, F; Poncelet, M; Santucci, V; Soubrié, P; Steinberg, R; Suaud-Chagny, MF; Vita, N | 1 |
| Heaulme, M; Le Fur, G; Leyris, R; Soubrie, P | 2 |
| Bernat, A; Gully, D; Herbert, JM; Laplace, MC; Lespy, L; Prabonnaud, V; Schaeffer, P | 1 |
| Casellas, P; Combes, T; Gully, D; Maffrand, JP; Portier, M | 1 |
| Bédard, PJ; Di Paolo, T; Falardeau, P; Goulet, M; Grondin, R; Morissette, M; Rostène, W | 1 |
| Matthews, RT | 1 |
| Kruse, CG; Long, SK; Nievelstein, H; Wadman, WJ; Werkman, TR | 1 |
| Trudeau, LE | 1 |
| Castagliuolo, I; Matthews, JB; Pothoulakis, C; Riegler, M; Sogukoglu, T; Wang, C; Wenzl, E; Wlk, M | 1 |
| Belmeguenai, A; Cavelier, F; Leprince, J; Louiset, E; Martinez, J; Vaudry, H; Vivet, B | 1 |
| Binder, EB; Kilts, CD; Kinkead, B; Nemeroff, CB; Owens, MJ | 1 |
| Hwang, HM; Li, AH; Tan, PP; Wang, HL; Yeh, TH | 1 |
| Brun, P; Leonetti, M; Renaud, B; Sotty, F; Soubrié, P; Steinberg, R; Suaud-Chagny, MF | 1 |
| Bert, L; Brun, P; Leonetti, M; Renaud, B; Sotty, F; Soubrié, P; Steinberg, R; Suaud-Chagny, MF | 1 |
| Meyer-Spasche, A; Piggins, HD; Reed, HE | 1 |
| Chen, L; Yung, KK; Yung, WH | 1 |
| Bérod, A; Colussi-Mas, J; Lambás-Señas, L; Panayi, F; Renaud, B; Scarna, H | 1 |
| Azmi, N; Bennett, GW; Norman, C; Spicer, CH | 1 |
| Cassaday, HJ; G W, B; Grimond-Billa, SK; Norman, C | 1 |
| Marie-Claire, C; Noble, F; Palminteri, S; Romualdi, P | 1 |
| Bennett, GW; Cassaday, HJ; Grimond-Billa, SK; Norman, C | 1 |
| Kawahara, H; Mitchell, VA; Vaughan, CW | 1 |
| Binder, EB; Cáceda, R; Kinkead, B; Nemeroff, CB | 1 |
24 other study(ies) available for adamantane and neurotensin
| Article | Year |
|---|---|
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Topics: Adamantane; Animals; Axonal Transport; Binding Sites; Brain; Calcium; Cell Line; Cell Membrane; CHO Cells; Corpus Striatum; Cricetinae; Dopamine; Female; Humans; Imidazoles; Inositol Phosphates; Male; Mice; Mice, Inbred Strains; Neurons; Neurotensin; Nucleus Accumbens; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Neurotensin; Recombinant Proteins; Stereotyped Behavior; Substantia Nigra; Transfection | 1997 |
Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.
Topics: Adamantane; Animals; Dopamine; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Male; Neurotensin; Nucleus Accumbens; Potassium; Pyrazoles; Quinolines; Rats; Receptors, Neurotensin; Visual Cortex | 1997 |
SR142948A is a potent antagonist of the cardiovascular effects of neurotensin.
Topics: Adamantane; Administration, Oral; Animals; Blood Pressure; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Hematocrit; Humans; Imidazoles; Injections, Intradermal; Iodine Radioisotopes; Male; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Umbilical Veins | 1998 |
Neurotensin type 1 receptor-mediated activation of krox24, c-fos and Elk-1: preventing effect of the neurotensin antagonists SR 48692 and SR 142948.
Topics: Adamantane; Animals; CHO Cells; Cricetinae; DNA-Binding Proteins; Dose-Response Relationship, Drug; ets-Domain Protein Elk-1; Genes, Reporter; Imidazoles; Neurotensin; Point Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Pyrazoles; Quinolines; Receptors, Neurotensin; Sequence Deletion; Signal Transduction; Transcription Factors | 1998 |
Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices.
Topics: Adamantane; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine Antagonists; Down-Regulation; Frontal Lobe; Hippocampus; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Neurotensin; Peptide Fragments; Potassium; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Serotonin; Tetrodotoxin | 1998 |
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Autoradiography; Binding Sites; Carrier Proteins; Caudate Nucleus; Denervation; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Imidazoles; In Situ Hybridization; Macaca fascicularis; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Neurotensin; Piperidines; Putamen; Receptors, Dopamine; Receptors, Neurotensin; RNA, Messenger; Substantia Nigra | 1999 |
Neurotensin depolarizes cholinergic and a subset of non-cholinergic septal/diagonal band neurons by stimulating neurotensin-1 receptors.
Topics: Action Potentials; Adamantane; Animals; Dose-Response Relationship, Drug; Female; Guinea Pigs; Histamine H1 Antagonists; Imidazoles; In Vitro Techniques; Male; Membrane Potentials; Neurons; Neurotensin; Patch-Clamp Techniques; Piperidines; Prosencephalon; Receptors, Neurotensin; Tetrodotoxin | 1999 |
Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area.
Topics: Action Potentials; Adamantane; Animals; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Electrophysiology; Imidazoles; In Vitro Techniques; Logistic Models; Male; Neurons; Neurotensin; Peptide Fragments; Quinpirole; Rats; Rats, Wistar; Receptors, Neurotensin; Substantia Nigra; Ventral Tegmental Area | 2000 |
Neurotensin regulates intracellular calcium in ventral tegmental area astrocytes: evidence for the involvement of multiple receptors.
Topics: Adamantane; Animals; Animals, Newborn; Astrocytes; Calcium; Cells, Cultured; Estrenes; Gadolinium; Imidazoles; Neurotensin; Peptide Fragments; Piperidines; Pyrrolidinones; Rats; Receptors, Neurotensin; Thapsigargin; Type C Phospholipases; Ventral Tegmental Area | 2000 |
Neurotensin stimulates Cl(-) secretion in human colonic mucosa In vitro: role of adenosine.
Topics: Adamantane; Adenosine; Adenosine Deaminase Inhibitors; Affinity Labels; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chlorides; Colon; Electrophysiology; Enteric Nervous System; Enzyme Inhibitors; Guanosine; Histamine; Humans; Imidazoles; In Vitro Techniques; Indomethacin; Intestinal Mucosa; Mast Cells; Membrane Potentials; Neurotensin; Pentostatin; Pyrazoles; Quinolines; Receptors, Neurotensin; Tetrodotoxin; Thioinosine; Thionucleosides | 2000 |
Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
Topics: Adamantane; Animals; Cells, Cultured; GTP-Binding Protein alpha Subunits, Gq-G11; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Heterotrimeric GTP-Binding Proteins; Imidazoles; Ligands; Male; Mammals; Melanocytes; Membrane Potentials; Neurotensin; Patch-Clamp Techniques; Peptide Fragments; Pituitary Gland; Pyrazoles; Quinolines; Rana ridibunda; Receptors, Neurotensin; Signal Transduction; Thionucleotides | 2000 |
Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.
Topics: Acoustic Stimulation; Adamantane; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Conditioning, Classical; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Female; Haloperidol; Imidazoles; Inhibition, Psychological; Neurotensin; Photic Stimulation; Psychomotor Performance; Quetiapine Fumarate; Rats; Rats, Long-Evans; Reaction Time; Receptors, Neurotensin; Reflex, Startle; RNA, Messenger; Schizophrenia; Social Isolation; Synaptic Transmission | 2001 |
Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms.
Topics: Adamantane; Animals; Calcium; Calcium Channels; Guanosine Diphosphate; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Ion Channels; Neurons; Neurotensin; Pyrazoles; Quinolines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Neurotensin; Serotonin; Thionucleotides | 2001 |
Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Topics: Adamantane; Animals; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Electrochemistry; Haloperidol; Imidazoles; Male; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stimulation, Chemical | 2001 |
The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Topics: Adamantane; Animals; Dopamine; Imidazoles; Male; N-Methylaspartate; Neurotensin; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Ventral Tegmental Area | 2002 |
Neurotensin phase-shifts the firing rate rhythm of neurons in the rat suprachiasmatic nuclei in vitro.
Topics: Action Potentials; Adamantane; Animals; Circadian Rhythm; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Imidazoles; Male; Neurons; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Wistar; Receptors, Neurotensin; Suprachiasmatic Nucleus; Type C Phospholipases | 2002 |
Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
Topics: Action Potentials; Adamantane; Anesthetics, Local; Animals; Electrophysiology; Globus Pallidus; Imidazoles; Neurons; Neurotensin; Organ Culture Techniques; Patch-Clamp Techniques; Peptide Fragments; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Synaptic Transmission; Tetrodotoxin | 2004 |
Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Topics: Adamantane; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Imidazoles; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Neurotensin; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Ventral Tegmental Area | 2005 |
Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.
Topics: Adamantane; Animals; Brain; Depression, Chemical; Discrimination, Psychological; Dose-Response Relationship, Drug; Form Perception; Imidazoles; Injections, Intraventricular; Male; Memory, Short-Term; Muscarinic Antagonists; Neurotensin; Rats; Receptors, Neurotensin; Scopolamine; Space Perception | 2006 |
Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect.
Topics: Adamantane; Animals; Association Learning; Avoidance Learning; Cognition; Conditioning, Operant; Cues; Dopamine Agonists; Dose-Response Relationship, Drug; Electroshock; Imidazoles; Male; Neurotensin; Rats; Rats, Wistar; Reinforcement, Psychology; Stimulation, Chemical | 2008 |
Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice.
Topics: 3,4-Methylenedioxyamphetamine; Adamantane; Analysis of Variance; Animals; Behavior, Animal; Conditioning, Operant; Corpus Striatum; Drug Interactions; Gene Expression Regulation; Hallucinogens; Imidazoles; Male; Mice; Motor Activity; Neurotensin; Receptors, Neurotensin; Time Factors | 2008 |
A neurotensin agonist and antagonist decrease and increase activity, respectively, but do not preclude discrete cue conditioning.
Topics: Adamantane; Animals; Appetitive Behavior; Association Learning; Dose-Response Relationship, Drug; Imidazoles; Male; Neurotensin; Rats; Rats, Wistar; Receptors, Neurotensin | 2010 |
Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
Topics: Adamantane; Animals; Cannabinoid Receptor Modulators; Endocannabinoids; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Imidazoles; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Miniature Postsynaptic Potentials; Neural Inhibition; Neurons; Neurotensin; Pain; Periaqueductal Gray; Piperidines; Presynaptic Terminals; Pyrazoles; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Neurotensin; Synaptic Transmission; Tetrodotoxin; Time Factors | 2009 |
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Topics: Acoustic Stimulation; Adamantane; Amphetamine; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Gene Expression Regulation; Imidazoles; Male; Neurotensin; Proto-Oncogene Proteins c-fos; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Reflex, Startle; RNA, Messenger | 2012 |